USP10 and hepatocellular carcinoma: Furthermore, targeting USP10 by either shRNAs or small‐molecule inhibitor Spautin‐1 evidently inhibits HCC metastasis, revealing that targeting USP10 could be a novel therapeutic strategy against HCC metastasis and the specific inhibitors of USP10 could be potential antimetastatic agents.